{"title":"饮食胰岛素血症潜能值与 COVID-19 患者疾病严重程度和症状的关系","authors":"Fatemeh Almasi , Mohammad Nemati , Minoo Akbarzadeh Morshedi , Zahra Karimzade , Armin Ebrahimzadeh , Seyed Gholam Abbas Mousavi , Azadeh Aminianfar , Alireza Milajerdi","doi":"10.1016/j.nupar.2024.07.003","DOIUrl":null,"url":null,"abstract":"<div><h3>Aim</h3><div>COVID-19 has threatened people's lives in world. Studies showed that level of insulin is related to function of immune system and level of inflammation in body. In this study we aimed to evaluate the association between dietary insulinemic potential and level of inflammatory biomarkers, severity and symptoms of COVID-19.</div></div><div><h3>Methods</h3><div>Participants of this cross-sectional study were 684 people who recovered from COVID-19. Dietary intake of participants was assessed using 168-item food frequency questionnaire during telephone interview, then dietary insulinemic index and load (DII and DIL) calculated for each participants. Data related to study outcomes, include levels of inflammatory biomarkers, disease symptoms, lung infection, saturation of peripheral oxygen, Respiratory Rate, need for respiratory support, duration of disease, hospitalization, recovery from disease and need for respiratory support and score of life satisfaction were collected through an interview with participants and review of their medical records.</div></div><div><h3>Results</h3><div>After controlling for confounders, participants in the highest quartile of DIL had a significantly higher risk of severe COVID-19 (OR: 2.66, 95% CI: 1.01–7.04, P<sub>trend</sub> <!-->=<!--> <!-->0.035), risk of hospitalization (OR: 3.44, 95% CI: 2.27-7.64, P<sub>trend</sub> <!-->><!--> <!-->0.001), fever (OR: 2.91, 95% CI: 8.08–1.05, <em>P</em><sub>trend</sub> <!-->=<!--> <!-->0.042), chills (OR: 4.68, 95% CI: 1.77–12.37, <em>P</em><sub>trend</sub> <!-->=<!--> <!-->0.002) and lower risk of weakness (OR: 0.28, 95% CI: 0.10–0.74, <em>P</em><sub>trend</sub> <!-->=<!--> <!-->0.012) and myalgia (OR:0.26, CI: 0.10–0.45, <em>P</em><sub>trend</sub> <!-->=<!--> <!-->0.006) compared to the lowest quartile. In addition our findings showed a significant positive association between DII and risk of fever (OR: 1.71 95% CI: 2.84–1.03, <em>P</em><sub>trend</sub> <!-->=<!--> <!-->0.049). Our finding failed to find a significand association between DII and risk of sever COVID-19 and hospitalization. Moreover we did not find significant association between DII/DIL and duration of disease, other symptoms and outcomes.</div></div><div><h3>Conclusions</h3><div>Our findings showed that higher DIL was associated with greater risk of sever COVID-19 and hospitalization. More detailed cohort studies are needed to confirm the findings.</div></div>","PeriodicalId":54702,"journal":{"name":"Nutrition Clinique et Metabolisme","volume":"38 4","pages":"Pages 259-270"},"PeriodicalIF":0.5000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Association of dietary insulinemic potential with disease severity and symptoms in patients with COVID-19\",\"authors\":\"Fatemeh Almasi , Mohammad Nemati , Minoo Akbarzadeh Morshedi , Zahra Karimzade , Armin Ebrahimzadeh , Seyed Gholam Abbas Mousavi , Azadeh Aminianfar , Alireza Milajerdi\",\"doi\":\"10.1016/j.nupar.2024.07.003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Aim</h3><div>COVID-19 has threatened people's lives in world. Studies showed that level of insulin is related to function of immune system and level of inflammation in body. In this study we aimed to evaluate the association between dietary insulinemic potential and level of inflammatory biomarkers, severity and symptoms of COVID-19.</div></div><div><h3>Methods</h3><div>Participants of this cross-sectional study were 684 people who recovered from COVID-19. Dietary intake of participants was assessed using 168-item food frequency questionnaire during telephone interview, then dietary insulinemic index and load (DII and DIL) calculated for each participants. Data related to study outcomes, include levels of inflammatory biomarkers, disease symptoms, lung infection, saturation of peripheral oxygen, Respiratory Rate, need for respiratory support, duration of disease, hospitalization, recovery from disease and need for respiratory support and score of life satisfaction were collected through an interview with participants and review of their medical records.</div></div><div><h3>Results</h3><div>After controlling for confounders, participants in the highest quartile of DIL had a significantly higher risk of severe COVID-19 (OR: 2.66, 95% CI: 1.01–7.04, P<sub>trend</sub> <!-->=<!--> <!-->0.035), risk of hospitalization (OR: 3.44, 95% CI: 2.27-7.64, P<sub>trend</sub> <!-->><!--> <!-->0.001), fever (OR: 2.91, 95% CI: 8.08–1.05, <em>P</em><sub>trend</sub> <!-->=<!--> <!-->0.042), chills (OR: 4.68, 95% CI: 1.77–12.37, <em>P</em><sub>trend</sub> <!-->=<!--> <!-->0.002) and lower risk of weakness (OR: 0.28, 95% CI: 0.10–0.74, <em>P</em><sub>trend</sub> <!-->=<!--> <!-->0.012) and myalgia (OR:0.26, CI: 0.10–0.45, <em>P</em><sub>trend</sub> <!-->=<!--> <!-->0.006) compared to the lowest quartile. In addition our findings showed a significant positive association between DII and risk of fever (OR: 1.71 95% CI: 2.84–1.03, <em>P</em><sub>trend</sub> <!-->=<!--> <!-->0.049). Our finding failed to find a significand association between DII and risk of sever COVID-19 and hospitalization. Moreover we did not find significant association between DII/DIL and duration of disease, other symptoms and outcomes.</div></div><div><h3>Conclusions</h3><div>Our findings showed that higher DIL was associated with greater risk of sever COVID-19 and hospitalization. More detailed cohort studies are needed to confirm the findings.</div></div>\",\"PeriodicalId\":54702,\"journal\":{\"name\":\"Nutrition Clinique et Metabolisme\",\"volume\":\"38 4\",\"pages\":\"Pages 259-270\"},\"PeriodicalIF\":0.5000,\"publicationDate\":\"2024-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nutrition Clinique et Metabolisme\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0985056224001171\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nutrition Clinique et Metabolisme","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0985056224001171","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
Association of dietary insulinemic potential with disease severity and symptoms in patients with COVID-19
Aim
COVID-19 has threatened people's lives in world. Studies showed that level of insulin is related to function of immune system and level of inflammation in body. In this study we aimed to evaluate the association between dietary insulinemic potential and level of inflammatory biomarkers, severity and symptoms of COVID-19.
Methods
Participants of this cross-sectional study were 684 people who recovered from COVID-19. Dietary intake of participants was assessed using 168-item food frequency questionnaire during telephone interview, then dietary insulinemic index and load (DII and DIL) calculated for each participants. Data related to study outcomes, include levels of inflammatory biomarkers, disease symptoms, lung infection, saturation of peripheral oxygen, Respiratory Rate, need for respiratory support, duration of disease, hospitalization, recovery from disease and need for respiratory support and score of life satisfaction were collected through an interview with participants and review of their medical records.
Results
After controlling for confounders, participants in the highest quartile of DIL had a significantly higher risk of severe COVID-19 (OR: 2.66, 95% CI: 1.01–7.04, Ptrend = 0.035), risk of hospitalization (OR: 3.44, 95% CI: 2.27-7.64, Ptrend > 0.001), fever (OR: 2.91, 95% CI: 8.08–1.05, Ptrend = 0.042), chills (OR: 4.68, 95% CI: 1.77–12.37, Ptrend = 0.002) and lower risk of weakness (OR: 0.28, 95% CI: 0.10–0.74, Ptrend = 0.012) and myalgia (OR:0.26, CI: 0.10–0.45, Ptrend = 0.006) compared to the lowest quartile. In addition our findings showed a significant positive association between DII and risk of fever (OR: 1.71 95% CI: 2.84–1.03, Ptrend = 0.049). Our finding failed to find a significand association between DII and risk of sever COVID-19 and hospitalization. Moreover we did not find significant association between DII/DIL and duration of disease, other symptoms and outcomes.
Conclusions
Our findings showed that higher DIL was associated with greater risk of sever COVID-19 and hospitalization. More detailed cohort studies are needed to confirm the findings.
期刊介绍：
Nutrition Clinique et Métabolisme is the journal of the French-speaking Society of Enteral and Parenteral Nutrition. Associating clinicians, biologists, pharmacists, and fundamentalists, the articles presented in the journal concern man and animals, and deal with organs and cells. The goal is a better understanding of the effects of artificial nutrition and human metabolism. Original articles, general reviews, update articles, technical notes and communications are published, as well as editorials and case reports.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
